PARSIPPANY, NJ, Jul 14, 2010 (MARKETWIRE via COMTEX) --

The Medicines Company (NASDAQ: MDCO) has scheduled its quarterly conference call for Wednesday, July 28, 2010 at 8:30 a.m. Eastern Time to discuss second quarter 2010 financial results and operational developments.

The conference call will be available via phone and webcast. The dial in information is listed below:

Domestic Dial In:                       866.362.5158
International Dial In:                  617.597.5397
Passcode for both dial in numbers:      83135911

Replay is available from 11:30 a.m. Eastern Time following the conference call through August 11, 2010. To hear a replay of the call dial 888-286-8010 (domestic) and 617-801-6888 (international). Passcode for both dial in numbers is 37130585.

This call is being webcast and can be accessed at The Medicines Company website at www.themedicinescompany.com.

About The Medicines Company

The Medicines Company (NASDAQ: MDCO) is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax(R) (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex(R) (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable. The Company's website is www.themedicinescompany.com.

Contact:
Michael Mitchell
973-290-6000
investor.relations@themedco.com

SOURCE: The Medicines Company

mailto:investor.relations@themedco.com